Aneratrigine

DB21639ExperimentalSmall molecule

Aneratrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Aneratrigine is a sodium channel blocker, signal transduction modulator. Aneratrigine has a... Aneratrigine has a monoisotopic molecular weight of 487.07 Da.

Mechanism: Pharmacologically active on Sodium channel protein type 9 subunit alpha
Curator reviewed
Formula / weight: C₁₉H₂₀ClF₂N₅O₂S₂ · 487.97 g/mol (avg)

Resolves to

Compound

UNII6A5ZY5LT78CAS2097163-74-9ChEMBLCHEMBL5314502ChEBI759206PubChem135325237

Structure

InChIKeyQQPQCLIQRLPULJ-UHFFFAOYSA-NSMILESCNCCN(C)C1=C(NC2=C(Cl)C=C(C(F)=C2)S(=O)(=O)NC2=CSC=N2)C=CC(F)=C1

Targets

Q15858SCN9A

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Aneratrigine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account